Items where authors include "Charrier, C."

Article

Moukengue, B., Brown, H.K., Charrier, C. et al. (11 more authors) (2020) TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model. EBioMedicine, 53. 102704. ISSN 2352-3964

Tellez-Gabriel, M., Charrier, C., Brounais-Le Royer, B. et al. (4 more authors) (2017) Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchip. European Journal of Cell Biology, 96 (2). pp. 110-118. ISSN 0171-9335

Chemel, M., Brion, R., Segaliny, A.I. et al. (7 more authors) (2017) Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts. American Journal of Pathology, 187 (1). pp. 156-162. ISSN 0002-9440

Cordova, L.A., Guilbaud, F., Amiaud, J. et al. (6 more authors) (2016) Severe Compromise of Preosteoblasts in a Surgical Mouse Model of Bisphosphonate-Associated Osteonecrosis of the Jaw. Journal of Craniomaxillofacial Surgery, 44 (9). pp. 1387-1394. ISSN 1010-5182

Rodriguez Calleja, L., Jacques, C., Lamoureux, F. et al. (13 more authors) (2016) ΔNp63α silences a microRNA program to aberrantly initiate a wound healing program that promotes TGFβ-induced metastasis. Cancer Research, 76 (11). pp. 3236-3251. ISSN 0008-5472

Segaliny, A.I., Brion, R., Brulin, B. et al. (4 more authors) (2015) IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization. Cytokine, 76 (2). pp. 170-181. ISSN 1043-4666

Ségaliny, A.I., Mohamadi, A., Dizier, B. et al. (7 more authors) (2015) Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. International Journal of Cancer , 137 (1). pp. 73-85. ISSN 0020-7136

Gobin, B., Baud'Huin, M., Lamoureux, F. et al. (8 more authors) (2015) BYL719, a new alpha-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. International Journal of Cancer, 136 (4). pp. 784-796. ISSN 0020-7136

Cordova, L.A., Trichet, V., Escriou, V. et al. (10 more authors) (2015) Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomaterialia, 13. pp. 150-158. ISSN 1742-7061

Gamblin, A.L., Renaud, A., Charrier, C. et al. (5 more authors) (2014) Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granules. Acta Biomaterialia, 10 (12). pp. 5139-5147. ISSN 1742-7061

Davaine, J-M., Quillard, T., Brion, R. et al. (10 more authors) (2014) Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability. PLoS ONE, 9 (9). e107642. ISSN 1932-6203

Teletchea, S., Stresing, V., Hervouet, S. et al. (6 more authors) (2014) Novel RANK Antagonists for the Treatment of Bone-Resorptive Disease: Theoretical Predictions and Experimental Validation. Journal of Bone and Mineral Research, 29 (6). pp. 1466-1477. ISSN 0884-0431

Odri, G., Kim, P-P., Lamoureux, F. et al. (6 more authors) (2014) Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration. BMC Cancer, 14. 169. ISSN 1471-2407

Gobin, B., Moriceau, G., Ory, B. et al. (5 more authors) (2014) Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models. PLoS ONE, 9 (3). e90795. ISSN 1932-6203

Picarda, G., Matous, E., Amiaud, J. et al. (8 more authors) (2013) Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL. Journal of Bone Oncology, 2 (3). pp. 95-104. ISSN 2212-1374

Heymann, M-F., Herisson, F., Davaine, J-M. et al. (6 more authors) (2012) Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds. Cytokine, 58 (2). pp. 300-306. ISSN 1043-4666

Baud'Huin, M., Charrier, C., Bougras, G. et al. (4 more authors) (2012) Proteoglycans and osteolysis. Proteoglycans, 836. pp. 323-337. ISSN 1064-3745

Herisson, F., Heymann, M-F., Chetiveaux, M. et al. (8 more authors) (2011) Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis, 216 (2). pp. 348-354. ISSN 0021-9150

David, E., Guihard, P., Brounais, B. et al. (10 more authors) (2011) Direct anti-cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer, 128 (8). pp. 1822-1835. ISSN 0020-7136

Baud'huin, M., Ruiz-Velasco, C., Jego, G. et al. (9 more authors) (2011) Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption. European Journal of Cell Biology, 90 (1). pp. 49-57. ISSN 0171-9335

Baud'huin, M., Ruiz-Velasco, C., Jego, G. et al. (9 more authors) (2011) Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption. European Journal of Cell Biology, 90 (1). pp. 49-57. ISSN 0171-9335

Moriceau, G., Ory, B., Mitrofan, L. et al. (11 more authors) (2010) Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research, 70 (24). pp. 10329-10339. ISSN 0008-5472

Rousseau, J., Escriou, V., Perrot, P. et al. (6 more authors) (2010) Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Therapy , 17 (6). pp. 387-397. ISSN 0929-1903

Baud'Huin, M., Renault, R., Charrier, C. et al. (6 more authors) (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. Journal of Pathology, 221 (1). pp. 77-86. ISSN 0022-3417

Le Goff, B., Soltner, E., Charrier, C. et al. (4 more authors) (2009) A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Research & Therapy, 11 (6). R185. ISSN 1478-6354

Baud'huin, M., Duplomb, L., Teletchea, S. et al. (4 more authors) (2009) Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival. The Journal of Biological Chemistry, 284 (46). pp. 31704-31713. ISSN 0021-9258

Brounais, B., David, E., Chipoy, C. et al. (8 more authors) (2009) Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone, 44 (5). pp. 830-839. ISSN 8756-3282

Mori, K., Blanchard, F., Charrier, C. et al. (6 more authors) (2008) Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk. Cancer Science, 99 (11). pp. 2170-2176. ISSN 1347-9032

Lamoureux, F., Picarda, G., Rousseau, J. et al. (6 more authors) (2008) Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Molecular Cancer Therapeutics, 7 (10). pp. 3389-3398. ISSN 1535-7163

Brounais, B., Chipoy, C., Mori, K. et al. (7 more authors) (2008) Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of midostaurin in vivo. Clinical Cancer Research, 14 (17). pp. 5400-5409. ISSN 1078-0432

Duplomb, L., Baud'huin, M., Charrier, C. et al. (4 more authors) (2008) Interleukin-6 inhibits receptor activator of nuclear factor kappa B ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: Key role of Serine(727) phosphorylation of signal transducer and activator of transcription 3. Endocrinology, 149 (7). pp. 3688-3697. ISSN 0013-7227

Perrot, P., Heymann, D. orcid.org/0000-0001-7777-0669, Charrier, C. et al. (3 more authors) (2007) Extraosseous bone formation obtained by association of mesenchymal stem cells with a periosteal flap in the rat. Annals of Plastic Surgery, 59 (2). pp. 201-206. ISSN 0148-7043

Mori, K., Le Goff, B., Charrier, C. et al. (3 more authors) (2007) DU145 human prostate cancer cells express functional receptor activator of NF kappa B: New insights in the prostate cancer bone metastasis process. Bone , 40 (4). pp. 981-990. ISSN 8756-3282

Heymann, D. orcid.org/0000-0001-7777-0669, Ory, B., Blanchard, F. et al. (7 more authors) (2005) Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone , 37 (1). pp. 74-86. ISSN 8756-3282